BMPR2 and pulmonary arterial hypertension: Mutations in the type II bone morphogenetic protein receptor (BMPR2), chronic inflammation, fibrosis, immune activation, and mitochondrial metabolic dysfunction are drivers for the pathogenesis of PAH (Thenappan et al., 2018).